Women's Health News

RSS

Abortion, other issues continue to stoke the politics surrounding health reform

Politico reports that "the issues of health care and abortion" are making the campaign tough for some Democrats. Among the vulnerable Democrats are Reps. Kathleen Dahlkemper, D-Pa.; Steve Driehaus, D-Ohio; and Indiana Reps. Joe Donnelly and Brad Ellsworth, who is running for Senate. "'We are going to do everything we can to point out that Democrats who said they were pro-life caved on the big one,' said Marilyn Musgrave, a former Colorado congresswoman.

28 Jul 2010

Cytori Therapeutics receives European approval for Celution System

Cytori Therapeutics received expanded European approval (CE Mark) for its Celution System, a medical device that extracts and separates stem and regenerative cells from a patient's own fat tissue. The new indications include key medical applications such as breast reconstruction, repair of soft tissue defects, as well as the facilitation of healing certain types of wounds, such as those resulting from Crohn's disease. This broadens Cytori's ability to offer the Celution System to patients and hospitals and further supports the company's efforts to gain treatment reimbursement.

28 Jul 2010

MabCure's MAbs 94% accurate in identifying ovarian cancer

Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.

28 Jul 2010

YesDTC, BioElectronics receive Japanese regulatory review notification for ActiPatch and Allay products

YesDTC Holdings, Inc., a direct-to-consumer marketer and global distributor of consumer goods and products and BioElectronics Corp., manufacturers of innovative pain relieving medical devices, today announced the companies have received notification of the pending review by Japanese government medical device regulators for the ActiPatch™ and Allay™ Menstrual Relief products. This review will take place on Wednesday, July 28th.

27 Jul 2010

First Edition: July 27, 2010

Today's health policy news includes reports about the continuing Senate backlash to Dr. Donald Berwick's appointment to head the Center for Medicare and Medicaid Services as well as findings from a new poll that reveal seniors really don't understand health reform.

27 Jul 2010

New York Times article highlights potential value of early cancer detection technology

Manhattan Scientifics, Inc. said today that a July 20th New York Times article titled "Prone to Error: Earliest Steps to Find Cancer" highlights the potential value of the early cancer detection technology developed by Senior Scientific, LLC and licensed by Manhattan Scientifics. The story focused on widespread problems associated with incorrect diagnosis of breast cancer, and cited one study in which 90,000 women either did not have the disease or their pathologist made an error that resulted in incorrect treatment.

27 Jul 2010

Life-saving interventions can save 11 million African women, children over next five years: Countdown report

In the next five years, 11 million African women and children could be saved by creating near-universal availability of key life-saving interventions, according to The Partnership for Maternal, Newborn & Child Health and the Countdown to 2015 Decade Report (2000-2010).

27 Jul 2010

Zetiq reports self declaration CE mark of conformity for cervical cancer diagnostic kit

Zetiq Technologies Ltd., a subsidiary of Bio-Light Ltd., reports that it has fulfilled the essential requirements towards issuing a self declaration CE mark of conformity for its diagnostic product for identification of cervical cancer in cytological specimens.

27 Jul 2010

Female sexual dysfunction can affect quality of life: Research

Almost two-thirds of females attending a general urology practice reported that they suffered from sexual dysfunction, according to a paper in the August issue of BJUI. Dysfunction rose with age in all categories except orgasm, with more than half of women aged from 18 to 30 reporting orgasm problems, significantly higher than women aged 31 to 54.

27 Jul 2010

AU leaders summit kicks off, focus on maternal and child health

Heads of state from the African Union (AU) started a three-day meeting in Kampala, Uganda, on Sunday as part of the 15th AU Summit, People's Daily Online reports. Leaders will focus on maternal and child health and will discuss several other issues, including agricultural development, food security, infrastructure development and economic integration (7/26).

27 Jul 2010

Abviva to receive patent for its new Mammastatin technology

Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks

27 Jul 2010

Obesity linked to early puberty in girls

A review of more than 100 studies found overweight girls tend to reach puberty earlier than their peers do.

26 Jul 2010

Obesity linked to rising womb cancer in women: Report

According to a new report from the Charity Cancer Research (CCR) in Britain, the number of women with womb cancer or uterine cancer is on the rise and obesity may be a clue to such rise.

26 Jul 2010

CUTCO Cutlery donates over a half million dollars to support Go Red For Women movement

In just over three years, CUTCO Cutlery has donated over a half million dollars to support the American Heart Association's Go Red For Women movement.

26 Jul 2010

Einstein scientists awarded $4.1M to test microbicide Carraguard against HPV

The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard- against the human papillomavirus, which causes cervical cancer. The research will evaluate the efficacy of Carraguard- - a clear gel made from the seaweed derivative carrageenan - in preventing new HPV infections in women.

26 Jul 2010

Tarsa Therapeutics completes patient enrollment in Phase III ORACAL trial of oral calcitonin

Unigene Laboratories, Inc. today noted that Tarsa Therapeutics has completed patient enrollment in the Phase III ORACAL trial of Tarsa's oral calcitonin product for the treatment of postmenopausal osteoporosis. Unigene licensed the product to Tarsa and owns 26% of the company.

23 Jul 2010

GRB7 gene drives an aggressive form of breast cancer, researchers find

Oregon Health & Science University Knight Cancer Institute researchers found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, known to be a stimulator of breast cancer growth. Isolating the role of this gene could ultimately help fine-tune a patient's treatment and enable physicians to provide a more accurate prognosis.

23 Jul 2010

GOP questions math of HHS' premium hike estimates; Abortion issue defining implementation

Senate Republican leaders are questioning an estimate by the Department of Health and Human Services that the effect of the new health law on insurance premiums will likely be less than 1 percent, The Hill reports.

23 Jul 2010

China Sky One Medical receives SFDA approval for producing Ciclopirox Olamine Vaginal Suppositories

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced that the Company has obtained approval from the State Food and Drug Administration in China for the production of Ciclopirox Olamine Vaginal Suppositories.

23 Jul 2010

Choice between late-term abortion or keeping an unhealthy foetus

Most pregnant women whose foetus is proven to have a genetic abnormality choose to have an abortion, but reaching that decision is a painful, exhausting process for most of them. "The women's doubt, pain and sorrow make abortion more moral - in the eyes of society as well as her own," says Sølvi Marie Risøy, a researcher at the Stein Rokkan Centre for Social Studies, University of Bergen.

23 Jul 2010

Women's Health News

Abortion, other issues continue to stoke the politics surrounding health reform

Cytori Therapeutics receives European approval for Celution System

MabCure's MAbs 94% accurate in identifying ovarian cancer

YesDTC, BioElectronics receive Japanese regulatory review notification for ActiPatch and Allay products

First Edition: July 27, 2010

New York Times article highlights potential value of early cancer detection technology

Life-saving interventions can save 11 million African women, children over next five years: Countdown report

Zetiq reports self declaration CE mark of conformity for cervical cancer diagnostic kit

Female sexual dysfunction can affect quality of life: Research

AU leaders summit kicks off, focus on maternal and child health

Abviva to receive patent for its new Mammastatin technology

Obesity linked to early puberty in girls

Obesity linked to rising womb cancer in women: Report

CUTCO Cutlery donates over a half million dollars to support Go Red For Women movement

Einstein scientists awarded $4.1M to test microbicide Carraguard against HPV

Tarsa Therapeutics completes patient enrollment in Phase III ORACAL trial of oral calcitonin

GRB7 gene drives an aggressive form of breast cancer, researchers find

GOP questions math of HHS' premium hike estimates; Abortion issue defining implementation

China Sky One Medical receives SFDA approval for producing Ciclopirox Olamine Vaginal Suppositories

Choice between late-term abortion or keeping an unhealthy foetus

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Latest News